Repligen Corp

Отворен

СекторЗдравеопазване

174.46 4.01

Преглед

Промяна на цената на акция

24 ч

Текуща

Минимум

165.33

Максимум

174.44

Ключови измерители

By Trading Economics

Приходи

-3.3M

5M

Продажби

9.9M

204M

P/E

Средно за сектора

226.487

56.597

EPS

0.54

Марж на печалбата

2.453

Служители

2,000

EBITDA

-35M

-2.4M

Препоръки

By TipRanks

Препоръки

Силна покупка

12-месечна прогноза

+9.64% upside

Дивиденти

By Acuity

Следващи печалби

27.10.2026 г.

Пазарни показатели

By TradingEconomics

Пазарна капитализация

2.1B

9.5B

Предишно отваряне

170.45

Предишно затваряне

174.46

Настроения в новините

By Acuity

34%

66%

60 / 339 Класиране в Healthcare

Repligen Corp Графика

Миналото представяне не гарантира бъдещи резултати.

Свързани новини

14.09.2026 г., 19:46 ч. UTC

Repligen Corp shares are higher today, continuing an upward trend since Friday. The stock has fluctuated within a range during the session.

11.09.2026 г., 21:01 ч. UTC

Repligen Corp shares are higher in after-market trading, continuing an upward trend since Friday's close. The stock remains below its 20-day moving average.

10.09.2026 г., 20:07 ч. UTC

Repligen Corp shares are lower amid broader market declines following the European Central Bank's interest rate hike and rising Treasury yields.

9.09.2026 г., 20:07 ч. UTC

Repligen Corp shares are lower during Wednesday's session, with no specific news identified. The stock remains significantly below its 20-day moving average.

8.09.2026 г., 22:21 ч. UTC

Repligen Corp shares declined in after-market trading, falling further from Tuesday's close and remaining near the lower end of their one-month trading range.

2.09.2026 г., 19:26 ч. UTC

Repligen Corp shares are higher during Wednesday's session, reaching a session high earlier today. The stock shows resilience amid broader market geopolitical tensions.

1.09.2026 г., 20:01 ч. UTC

Repligen Corp shares are lower today, continuing a decline from Monday's close amid rising oil prices and inflation concerns affecting market conditions.

31.08.2026 г., 21:02 ч. UTC

Repligen Corp shares are lower in after-market hours amid broader economic concerns and hawkish comments from Fed Chair Kevin Warsh on inflation and interest rates.

28.08.2026 г., 23:01 ч. UTC

Repligen Corp shares are higher in after-market hours, reflecting strong momentum and positioning near the upper end of their one-month trading range.

26.08.2026 г., 19:46 ч. UTC

News

Repligen Corp shares are lower during Wednesday's session amid broader market volatility and persistent inflationary pressures reflected in recent PCE data.

25.08.2026 г., 22:01 ч. UTC

Repligen Corp shares are lower in after-market trading, reflecting broader market caution ahead of key economic events and a drop in consumer confidence.

24.08.2026 г., 19:36 ч. UTC

Repligen Corp shares are higher today, continuing an upward trend since Friday. The stock showed volatility, peaking earlier in the session.

21.08.2026 г., 22:31 ч. UTC

Correlated Moves

Repligen Corp's after-market performance is roughly flat, reflecting a slight decline since Friday's close amid broader market weakness in the life sciences sector.

20.08.2026 г., 19:51 ч. UTC

Repligen Corp is gaining during Thursday's session, supported by strong movement in the Life Sciences Tools & Services sub-sector. Shares pulled back earlier but have advanced.

19.08.2026 г., 20:02 ч. UTC

Repligen Corp is advancing sharply, supported by gains in the Life Sciences Tools & Services sub-sector. The stock remains above its 20-day moving average.

18.08.2026 г., 19:36 ч. UTC

Repligen Corp shares are declining, continuing a downward trend since Monday. Broader market sentiment remains cautious amid rising treasury yields and inflation concerns.

14.08.2026 г., 19:16 ч. UTC

Repligen Corp shares are lower today amid a lack of specific news. Investor sentiment is cautious following a decline in U.S. retail sales.

13.08.2026 г., 22:01 ч. UTC

Repligen Corp shares are lower in after-market hours, dropping from a brief high. The price remains above its 20-day moving average.

12.08.2026 г., 19:36 ч. UTC

Repligen Corp shares are higher today amid broader market optimism following a modest increase in the core Consumer Price Index. No specific company news was identified.

11.08.2026 г., 20:01 ч. UTC

Repligen Corp shares are higher today, reflecting strong performance amid routine trading. The stock remains above its 20-day moving average.

10.08.2026 г., 23:16 ч. UTC

Repligen Corp shares are trading higher in after-market hours. The stock remains near the upper end of its one-month trading range.

7.08.2026 г., 22:01 ч. UTC

Repligen Corp shares are higher in after-market trading, continuing a trend of six consecutive sessions. Broader equity gains follow weaker employment data easing rate hike concerns.

6.08.2026 г., 20:02 ч. UTC

Repligen Corp shares are higher today, continuing gains from Wednesday. No specific company news was identified to explain the movement.

5.08.2026 г., 20:02 ч. UTC

Correlated Moves

Repligen Corp shares are higher today, bolstered by gains in Charles River Laboratories and positive sentiment in the life sciences sector.

4.08.2026 г., 19:56 ч. UTC

Repligen Corp shares are higher today, reflecting broader market strength amid a significant decline in crude oil prices. The stock is near its one-month range's upper end.

31.07.2026 г., 20:02 ч. UTC

Repligen Corp shares are lower today amid broader market pressures and rising US Treasury yields. The stock reached a session low earlier.

30.07.2026 г., 21:02 ч. UTC

Repligen Corp shares are higher in after-market trading, buoyed by positive investor sentiment amid a focus on corporate earnings and broader market trends.

29.07.2026 г., 16:12 ч. UTC

Repligen Corp shares are lower Wednesday, breaking a trend of higher daily closes. Broader market conditions reflect rising crude oil prices and inflation concerns.

28.07.2026 г., 23:21 ч. UTC

Repligen Corp shares are higher in after-market trading, reflecting strong momentum and trading near the upper end of its one-month range.

27.07.2026 г., 16:26 ч. UTC

News

Repligen Corporation shares are lower as the company approaches its Q2 earnings report, with analysts projecting 10.7% revenue growth. Current price is $131.96.

Сравнение с други в отрасъла

Ценова промяна

Repligen Corp Прогноза

Ценова цел

By TipRanks

9.64% нагоре

12-месечна прогноза

Среден 184.2 USD  9.64%

Висок 225 USD

Нисък 145 USD

Според 12 анализатори от Wall Street, предложили 12-месечна ценова цел за Repligen Corp през последните три месеца.

Консенсусна оценка

By TipRanks

Силна покупка

12 ratings

11

Купи

1

Задържане

0

Продай

Настроение

By Acuity

60 / 339 Класиране в Здравеопазване

Настроения в новините

Бичи доказателства

Волатилност

Под средното

Обем новини (RCV)

Под средното

Финанси

Продажбени и админисративни разходи

Оперативни разходи

Печалба преди облагане с данъци

Продажби

Разходи за продажби

Брутна печалба от продажби

Разходи за лихви по дълг

EBITDA

Оперативна печалба

$

Относно Repligen Corp

Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products. The company's chromatography products include OPUS pre-packed chromatography columns, which are used in the purification of biologics; and OPUS smaller-scale columns that are used in the high throughput process development screening, viral clearance validation studies, and scale down validation of chromatography processes. It also offers ELISA test kits; and chromatography resins under the CaptivA brand. In addition, the company provides filtration products, such as XCell Alternating Tangential Flow systems that are filtration devices used in upstream perfusion and cell culture processing; TangenX flat sheet cassettes, which are used in downstream biologic drug concentration, buffer exchange, and formulation processes; KrosFlo tangential flow filtration and tangential flow depth filtration systems; Spectra/Por laboratory and process dialysis products, and ProConnex TFDF flow paths. Further, it provides process analytics products, such as slope spectroscopy systems under the SoloVPE, FlowVPE, and FlowVPX brands. The company sells its products to life sciences, biopharmaceutical, and diagnostics companies; laboratory researchers; and contract manufacturing organizations. Repligen Corporation has collaboration agreements with Navigo Proteins GmbH to develop multiple affinity ligands. The company was incorporated in 1981 and is headquartered in Waltham, Massachusetts.
help-icon Live chat